Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.
All physicians increasingly will encounter patients who have implanted cardioverter-defibrillators (ICDs) for protection from ventricular arrhythmias. This advisory provides a concise summary relevant to the assessment and management of patients with ICDs, including those who present to primary care or emergency department physicians with symptoms suggesting arrhythmia or ICD malfunction and those who require cardiac or surgical procedures.
Stevenson
William G
WG
Chaitman
Bernard R
BR
Ellenbogen
Kenneth A
KA
Epstein
Andrew E
AE
Gross
Wendy L
WL
Hayes
David L
DL
Strickberger
S Adam
SA
Sweeney
Michael O
MO
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use; D019090:Case Management; D003131:Combined Modality Therapy; D000075202:Contraindications; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control; D017147:Defibrillators, Implantable / Q000009:adverse effects; D004554:Electric Countershock / Q000009:adverse effects; D004556:Electric Injuries / Q000209:etiology; D004564:Electrocoagulation; D004630:Emergencies; D004868:Equipment Failure; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control; D008279:Magnetic Resonance Imaging; D008280:Magnetics / Q000009:adverse effects; D013530:Surgical Wound Infection / Q000209:etiology; D017180:Tachycardia, Ventricular / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D014693:Ventricular Fibrillation / Q000150:complications / Q000188:drug therapy / Q000628:therapy*
D000889:Anti-Arrhythmia Agents